VTAK — Catheter Precision Share Price
0.000.00%
Last trade - 00:00- $2.98m
- $1.78m
- $0.42m
- 18
- 39
- 16
- 13
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.25 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 7.09 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -43.77% | ||
| Return on Equity | -132.33% | ||
| Operating Margin | -2676.9% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 0.26 | 0.02 | 0.01 | 0.44 | 0.42 | 3.8 | 10.2 | -19.89% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing a kit of tools to enable physicians to gain access to the pericardial space of the heart.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 14th, 2018
- Public Since
- September 27th, 2018
- No. of Shareholders
- 79
- No. of Employees
- 22
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NYSE MKT
- Shares in Issue
- 10,268,632
- Address
- 1670 HIGHWAY 160 WEST, SUITE 205, FORT MILL, 29708
- Web
- https://www.ramed.com/
- Phone
- +1 9736912000
- Contact
- Tony Dacosta
- Auditors
- WithumSmith Brown PC
Upcoming Events for VTAK
Catheter Precision Inc Annual Shareholders Meeting
Q2 2025 Catheter Precision Inc Earnings Release
Similar to VTAK
Acme United
NYSE MKT
Alpha Pro Tech
NYSE MKT
Electromed
NYSE MKT
Infusystem Holdings
NYSE MKT
Know Labs
NYSE MKT
FAQ
What is the Catheter Precision share price?
As of Today at 19:48 UTC, shares in Catheter Precision are trading at $0.29. This share price information is delayed by 15 minutes.
How has the Catheter Precision share price performed this year?
Shares in Catheter Precision last closed at $0.29 and the price had moved by -94.73% over the past 365 days. In terms of relative price strength the Catheter Precision share price has underperformed the S&P500 Index by -95.14% over the past year.
What are the analyst and broker recommendations for Catheter Precision?
The overall consensus recommendation for Catheter Precision is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Catheter Precision dividend yield?
Catheter Precision does not currently pay a dividend.
Does Catheter Precision pay a dividend?
Catheter Precision does not currently pay a dividend.
When does Catheter Precision next pay dividends?
Catheter Precision does not currently pay a dividend.
How do I buy Catheter Precision shares?
To buy shares in Catheter Precision you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Catheter Precision?
As of the previous close price of $0.29, shares in Catheter Precision had a market capitalisation of $2.98m.
Where are Catheter Precision shares listed?
Here are the trading details for Catheter Precision:
- Country of listing: United States
- Exchange: ASQ
- Ticker Symbol: VTAK
What kind of share is Catheter Precision?
Based on an overall assessment of its quality, value and momentum Catheter Precision is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Catheter Precision share price forecast for 2025?
The analyst consensus target price for shares in Catheter Precision is $2.00. That is 590.13% above the last closing price of $0.29.
Analysts covering Catheter Precision currently have a consensus Earnings Per Share (EPS) forecast of -$0.63 for the next financial year.
Find out moreWhat is the trend in the Catheter Precision share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Catheter Precision. Over the past six months, its share price has underperformed the S&P500 Index by -50.74%.
As of the last closing price of $0.29, shares in Catheter Precision were trading -59.97% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Catheter Precision PE Ratio?
The Catheter Precision PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.29.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Catheter Precision?
We do not have data on Catheter Precision's directors